Patent · US Active

Pharmaceutical compositions comprising DGLA and/or 15-HETrE and methods of use thereof

US8936803B2 · kind B2 · utility

5Cited by
0References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 19, 2012
Grant dateJan 20, 2015
Priority date—
Expiry dateOct 27, 2032

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61Q19/004
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure provides compositions comprising fatty acids, or derivatives thereof (e.g., C1-C4 esters) including, for example, DGLA, and/or 15-HETrE, used singly or in combination for the prevention and/or treatment of effects associated with UV radiation such as erythema.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.